Back to search

Article

Digital risk score sensitively identifies presence of α-synuclein aggregation or dopaminergic deficit

2024-09-06

Abstract excerpt

<h4>Background</h4> Use of digital sensors to passively collect long-term offers a step change in our ability to screen for early signs of disease in the general population. Smartwatch data has been shown to identify Parkinson’s disease (PD) several years before the clinical diagnosis, however, has not been evaluated in comparison to biological and pathological markers such as dopaminergic imaging (DaTscan) or cer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0196eee9-5ebe-59d9-b0ea-51e3c1701e8a
DOI
10.1101/2024.09.05.24313156
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Digital risk score sensitively identifies presence of α-synuclein aggregation or dopaminergic deficitDOI 10.1101/2024.09.05.24313156
Wearable devices can identify Parkinson’s disease up to 7 years before clinical diagnosisSemantic proximity
Parkinson’s Disease: From Gene–Environment Risk to Precision TherapySemantic proximity
Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical DataSemantic proximity
Diagnostic and prognostic value of alpha-synuclein seed amplification assay in Parkinson’s disease: a longitudinal cohort studySemantic proximity
Accelerometry-Derived REM Sleep Behavior Disorder Predicts Future Parkinson’s Disease in the UK BiobankSemantic proximity
Integrated Genetic, Molecular, and Wearable Sensor Biomarkers Enable Bayesian Machine Learning-Driven Precision Stratification in Parkinson’s Disease: A Comprehensive Multi-Cohort Validation StudySemantic proximity
From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity
Parkinson's Disease: From Gene-Environment Risk to Precision Therapy.Semantic proximity
Faster reaction times of CSF Alpha-Synuclein Seed Amplification Assay predict the Diffuse Malignant subtype of Parkinson’s Disease at 10-year follow-upSemantic proximity
Assessment of heterogeneity and disease onset in the Parkinson’s Progression Markers Initiative (PPMI) cohort using the α-synuclein seed amplification assay: a cross-sectional studySemantic proximity
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson’s disease in the PPMI cohortSemantic proximity
Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disordersSemantic proximity
Select a neighboring publication to make it the new centre.